Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects (NSERC partnered)

University of Toronto

$632,425.00

Next-Generation Antimicrobial Diagnostics: Speed and Precision via Whole Genome Sequencing

EF 2016-17

Résumé
Bacterial infections cause millions of infections and take tens of thousands of lives every year, and without antibiotics the death toll would skyrocket. Unfortunately, antibiotics are rapidly becoming less effective due to the evolution of resistance. On top of this, doctors often have a difficult time identifying what drugs will be most effective against infecting pathogens a timely manner. For these reasons there is desperate need for new antimicrobial diagnostic methods that can rapidly provide physicians accurate information to guide their treatments. One very promising new approach to this problem is to sequence the genomes of the infecting pathogens and use this information predict how they will respond to treatment. We propose to produce genome sequence data and use sophisticated genome-wide association and predictive modeling methods to develop a new antimicrobial diagnostic tool. We will specifically focus on stopping a bacterial pathogen called Pseudomonas aeruginosa that causes a disproportionate number of hospital infections and deaths. We will work in collaboration with our partners at the Hospital for Sick Children in Toronto to generate this state-of-the-art diagnostic tool and then develop procedures to move it into the clinic. The success of this project will speed diagnosis, improve patient care, reduce healthcare costs, and enhance stewardship of antibiotics; thereby, preserving their efficacy for the future.
Programme
Collaborative Health Research Projects (NSERC partnered)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
361209
Name
Guttman David S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
Next-Generation Antimicrobial Diagnostics: Speed and Precision via Whole Genome Sequencing
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$632,425
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Antibiotic Resistance; Diagnostic Testing; Genome Analysis; Genome-Wide Association Study; Human Health; Infectious Diseases; Microbiology; Predictive Modeling; Pseudomonas Aeruginosa
Abstract
Bacterial infections cause millions of infections and take tens of thousands of lives every year, and without antibiotics the death toll would skyrocket. Unfortunately, antibiotics are rapidly becoming less effective due to the evolution of resistance. On top of this, doctors often have a difficult time identifying what drugs will be most effective against infecting pathogens a timely manner. For these reasons there is desperate need for new antimicrobial diagnostic methods that can rapidly provide physicians accurate information to guide their treatments. One very promising new approach to this problem is to sequence the genomes of the infecting pathogens and use this information predict how they will respond to treatment. We propose to produce genome sequence data and use sophisticated genome-wide association and predictive modeling methods to develop a new antimicrobial diagnostic tool. We will specifically focus on stopping a bacterial pathogen called Pseudomonas aeruginosa that causes a disproportionate number of hospital infections and deaths. We will work in collaboration with our partners at the Hospital for Sick Children in Toronto to generate this state-of-the-art diagnostic tool and then develop procedures to move it into the clinic. The success of this project will speed diagnosis, improve patient care, reduce healthcare costs, and enhance stewardship of antibiotics; thereby, preserving their efficacy for the future.
Competitiondate
201610
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Guttman, David S; Coburn, Bryan A; Hwang, David M; Shapiro, Jesse
Approvedterm
3 ans 0 mois
Cihrcontribution2
Major Initiatives #2~ $632,425~ $0~